Insmed Inc. buy Rothschild & Co Redburn
Start price
04.12.25
/
50%
€179.00
Target price
04.12.26
€225.50
Performance (%)
-31.43%
Price
17.04.26
€120.36
Summary
This prediction is currently active. The BUY prediction by Rothschild___Co_Redb for Insmed Inc. is performing very badly with a performance of -31.43%. This prediction currently runs until 04.12.26. The prediction end date can be changed by Rothschild___Co_Redb at any time. Rothschild___Co_Redb has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Insmed Inc. | -8.290% | -8.290% |
| iShares Core DAX® | 3.593% | 3.931% |
| iShares Nasdaq 100 | 5.810% | 5.518% |
| iShares Nikkei 225® | 4.075% | 8.460% |
| iShares S&P 500 | 4.142% | 4.039% |
Comments by Rothschild___Co_Redb for this prediction
In the thread Insmed Inc. diskutieren
Insmed (NASDAQ:INSM) is now covered by analysts at Rothschild & Co Redburn. They set a "buy" rating and a $263.00 price target on the stock.
Ratings data for INSM provided by MarketBeat